Business Standard

Solara Active Pharma surges 19% on heavy volumes, hits record high

Global brokerage Macquarie Capital Securities, on October 6, initiated coverage on the stock with an 'Outperform' rating and a target price of Rs 2,064 in bull-case scenario

The government is now trying to understand how long it will take before the drug’s production can start in India
Premium

In the past eight trading days, market price of Solara Active Pharma Sciences has soared 34 per cent

SI Reporter Mumbai
Shares of Solara Active Pharma Sciences hit a record high of Rs 1,245, up 19 per cent on the BSE, in the intra-day trade on Wednesday on the back of heavy volumes. Stock of the smallcap pharmaceutical company surpassed its previous high of Rs 1,114 touched on September 30, 2020.

Global brokerage Macquarie Capital Securities, on October 6, initiated coverage on the stock with an 'Outperform' rating and a target price of Rs 2,064 in bull-case scenario.

Analysts at the brokerage expect Solara's strategy of working with customers on a long-term basis (50-60 per cent contracts are long-term) rather than

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in